MARKET

RAPH

RAPH

Raphael Pharm
OTCMQB
1.000
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
1.000
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.000
52 WEEK LOW
0.150
MARKET CAP
19.63M
P/E (TTM)
-13.8122
1D
5D
1M
3M
1Y
5Y
1D
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
Barchart · 11/17 11:03
Weekly Report: what happened at RAPH last week (0908-0912)?
Weekly Report · 09/15 11:51
Raphael Pharmaceutical Inc. Files Initial Statement of Beneficial Ownership for Director Zvi Laufer
Reuters · 09/08 20:29
Weekly Report: what happened at RAPH last week (0901-0905)?
Weekly Report · 09/08 11:53
Weekly Report: what happened at RAPH last week (0825-0829)?
Weekly Report · 09/01 11:47
Weekly Report: what happened at RAPH last week (0818-0822)?
Weekly Report · 08/25 12:01
Weekly Report: what happened at RAPH last week (0811-0815)?
Weekly Report · 08/18 11:51
Raphael Pharmaceutical Inc. Announces Board Changes: Dr. Igal Louria Hayon Resigns, Zvi Laufer Laor Appointed as New Director
Reuters · 08/11 20:08
More
About RAPH
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company. The Company is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The Company is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.

Webull offers Raphael Pharmaceutical Inc stock information, including OTCMQB: RAPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RAPH stock methods without spending real money on the virtual paper trading platform.